Search Results

60 results

  1. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP 47

    In field photonic sensing of tobacco leaves for the non-destructive assessment of nitrogen content and quality prediction

    TUCCIO L.(1); BARGIACCHI E.(2); MILLI G.(3); MIELE S.(2); AGATI G.(1)
    (1) CNR-IFAC, Sesto Fiorentino, FI, Italy; (2) Consortium INSTM, Firenze, Italy; (3) Fattoria Autonoma Tabacchi (FAT) & ITT, Città di Castello, PG, Italy
    Nitrogen (N) fertilisation is one of the most important aspects of tobacco cultivation. Right N rates increase leaf yield and quality, and influence vegetative cycle, disease resistance, leaf nicotine and sugar content. Good N availability to the...
  2. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP Sustainability Forum

    Agro-Phyto Sustainability Forum

    WILDE L.(1); PRIBIC V.(2); EVANS W.(3); ROYO E.(4); BARGIACCHI E.(5); COLARD S.(6)
    (1) twentyfifty Ltd, Frome, U.K.; (2) JT International S.A., Geneva, Switzerland; (3) Imperial Tobacco Limited, Durban, South Africa; (4) Philip Morris International, Cape Town, South Africa; (5) Consortium INSTM, Firenze, Italy; (6) CORESTA, Paris, France
    In 2015, the United Nations published 17 sustainable development goals and their corresponding targets to be achieved by 2030. Like other sectors, the tobacco and alternative product sectors are likely to impact most of the...
  3. 48th TWC, Tob. Work. Conf., 2018, abstr. 24

    No evidence of claimed nicotine pollution in an intensively Kentucky tobacco cropped area in central Italy. Preliminary results of an environmental and plant products research

    BARGIACCHI E.; MIELE S.
    Italian Interuniversity Consortium for Science and Technology of Materials, Firenze Italy
    Italian Kentucky (KY) tobacco is concentrated in Tuscany and Lazio, with 1,700 Ha in the High Tiber Valley, to produce Tuscan cigar wrapping. Recently, this KY area has been interested by farmers growing organic medicinal plants near tobacco or...
  4. CORESTA Congress, Kunming, 2018, Agronomy/Phytopathology Groups, AP 46

    New strategies for early detection of blue mold in asymptomatic tobacco: a mixed fluorescence and LAMP based-approach under preliminary test at Fattoria Autonoma Tabacchi

    BARGIACCHI E.(1); TUCCIO L.(2); AGATI G.(2); CERBONESCHI M.(3); MILLI G.(4); MIELE S.(1)
    (1) Consortium INSTM, Firenze, Italy; (2) CNR-IFAC, Sesto Fiorentino, Italy; (3) DiSPAA-UniFI, Lab Molecular Plant Pathology, Firenze, Italy; (4) Fattoria Autonoma Tabacchi (FAT) & ITT, Città di Castello, Italy
    One of the fundamental criteria of integrated pest management (IPM) is that crops should be treated only when monitored pest and disease exceed their critical thresholds. Also, zero-residue tobacco represents not only a target of social...
  5. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 25

    Misperception of e-cigarette harm growing among American adults, 2013-2015

    VERRON T.(1); GUO M.(1); VARIGNON B.(1); O'CONNELL G.(2); WALELE T.(2); CAHOURS X.(1)
    (1) SEITA - Imperial Brands plc, Paris, France; (2) Fontem Ventures B.V., Amsterdam, The Netherlands
    Electronic cigarettes (e cigarettes) have been characterised as significantly less harmful than smoked tobacco by an increasing number of public health authorities. However, the proportion of American adults who perceive e cigarettes to be equally or...
  6. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 52

    Biological test procedure for fresh generated cigarette smoke and e-cigarette aerosols under air-liquid interface (ALI) exposure in 24 and 96 multi-well plates

    WIECZOREK R.(1); TRELLES STICKEN E.(1); WALELE T.(2); CZEKALA L.(3); SIMMS L.(3)
    (1) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (2) Fontem Ventures, Amsterdam, The Netherlands; (3) Imperial Tobacco Limited, Bristol, U.K.
    Cigarette smoke and e cigarette aerosol contain particulate matter/liquid droplets in the solid phase as well as volatile substances in the gas phase. Both fractions are of potential toxicological relevance and should be considered when assessing...
  7. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 53

    Use of human derived cell lines to increase the biological relevance of cigarette condensate, non-tobacco materials and e-liquids testing

    WIECZOREK R.(1); TRELLES STICKEN E.(1); WALELE T.(2); CZEKALA L.(3); SIMMS L.(3)
    (1) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (2) Fontem Ventures, Amsterdam, The Netherlands; (3) Imperial Tobacco Limited, Bristol, U.K.
    The in vitro testing strategy of tobacco products is mainly based on the testing of extracts from cigarette smoke condensates. An accepted industry wide assay battery has been developed over recent years which delivers reliable results for the...
  8. CORESTA Meeting, Agronomy/Phytopathology, 2017, Santa Cruz do Sul, AP 03

    Project SOSTAB: innovative traceability on the tobacco production chain in Italy

    BURLA G.(1); MILLI G.(2)
    (1) TTI - Italian Consortium of Tobacco Processing, Città di Castello, Italy; (2) Fattoria Autonoma Tabacchi (FAT), I-06012 Città di Castello, Italy
    The Italian tobacco production chain has evolved significantly over the last twenty years, and several different activities have converged into larger processing units, which interface themselves with international buyers. Therefore, common targets...
  9. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 62

    Overview of in vitro methods used to assess e-cigarettes based on “Toxicity Testing in 21st Century” principles

    SIMMS L.(1); STEVENSON M.(1); CZEKALA L.(1); TSCHIERSKE N.(1); WALELE T.(2)
    (1) Imperial Tobacco Ltd, Bristol, U.K.; (2) Fontem Ventures B.V. (an Imperial Brands PLC Company), Amsterdam, The Netherlands
    When the National Academies of Sciences released “Toxicity Testing in the 21st Century: A Vision and a Strategy” a new toxicological paradigm was created, focusing on the use of human cell lines and the disruption of key cellular pathways. In keeping...